Forbes December 4, 2018
When it comes to healthcare, regulation is vital. Without it, doctors and patients cannot know what drugs, products and services are safe, exposing us all to greater uncertainty and unacceptable levels of risk.
However, regulation is far from easy – especially in healthtech, where the rise of digital and mobile technologies has seen the pace of innovation accelerate markedly. Regulatory processes are rarely designed with speed and agility in mind and, as a result, existing structures and institutions have struggled to cope with this rapid influx of new players and products.
This is understandable, but with the newest wave of healthtech innovations set to pose a series of regulatory questions never faced before, we have to overcome these challenges. Failure...
Today's Sponsors
Today's Sponsor